Fresenius Kabi Oncology Financials
NSE: FKONCO | BSE: 532545
₹132.50
As on 02-Jan-2014IST
Market cap
₹2,255 Cr
Revenue (TTM)
₹813 Cr
P/E Ratio
--
P/B Ratio
3.6
Div. Yield
0 %
Income Statement (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
813.05
|
786.43
|
717.14
|
667.27
|
602.59
|
629.87
|
|||||
|
Total Income
|
848.26
|
814.91
|
756.19
|
705.39
|
638.82
|
666.11
|
|||||
|
Total Expenditure
|
685.51
|
676.91
|
637.93
|
588.60
|
524.13
|
545.94
|
|||||
|
EBITDA
|
127.55
|
109.51
|
79.21
|
78.67
|
78.46
|
83.93
|
|||||
|
Depreciation
|
52.05
|
58.87
|
54.07
|
53.01
|
53.77
|
57.86
|
|||||
|
EBIT
|
75.50
|
50.65
|
25.14
|
25.66
|
24.69
|
26.07
|
|||||
|
Interest
|
9.51
|
6.73
|
9.98
|
16.45
|
37.31
|
39.89
|
|||||
|
Other Income
|
35.20
|
28.49
|
39.05
|
38.12
|
36.23
|
36.24
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
-369.41
|
-22.57
|
|||||
|
Profit before Tax
|
101.19
|
72.41
|
54.21
|
47.32
|
-345.79
|
-0.15
|
|||||
|
Provision for Tax
|
26.06
|
18.21
|
8.92
|
11.76
|
-9.63
|
-19.29
|
|||||
|
Profit after Tax
|
75.13
|
54.20
|
45.29
|
35.56
|
-336.16
|
19.14
|
Liabilities (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,411.36
|
1,335.24
|
1,279.73
|
1,230.69
|
58.53
|
395.64
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
156.12
|
149.69
|
254.03
|
131.22
|
222.41
|
399.83
|
|||||
|
Current Liabilities
|
307.18
|
508.57
|
398.48
|
314.03
|
1,153.09
|
541.18
|
|||||
|
Total Liabilities
|
1,874.66
|
1,995.24
|
1,952.30
|
1,705.84
|
1,476.00
|
1,368.40
|
Assets (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
694.42
|
651.42
|
694.10
|
615.51
|
589.62
|
616.53
|
|||||
|
Current Assets
|
1,180.24
|
1,342.09
|
1,238.15
|
1,060.43
|
844.40
|
720.12
|
|||||
|
Total Assets
|
1,874.66
|
1,995.24
|
1,952.30
|
1,705.84
|
1,476.00
|
1,368.40
|
|||||
|
Total Debt*
|
117.72
|
156.62
|
150.75
|
29.00
|
593.85
|
476.50
|
|||||
|
Net Current Assets
|
873.06
|
833.52
|
839.67
|
746.40
|
-308.68
|
178.94
|
|||||
|
Contingent Liabilities
|
161.34
|
179.20
|
213.32
|
213.77
|
152.08
|
152.87
|
Cashflow (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-63.76
|
174.54
|
23.68
|
-459.75
|
0.02
|
77.01
|
|||||
|
Cash Flow from Investing Activities
|
-46.22
|
-57.72
|
-96.26
|
-58.89
|
-44.58
|
-46.24
|
|||||
|
Cash from Financing Activities
|
-77.73
|
-6.69
|
102.07
|
556.14
|
49.12
|
-32.97
|
|||||
|
Net Cash Inflow / Outflow
|
-187.70
|
110.13
|
29.49
|
37.50
|
4.56
|
-2.21
|
Financials Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
1.56
|
1.13
|
0.94
|
0.74
|
-20.34
|
1.16
|
|||||
|
Cash EPS (₹)
|
2.65
|
2.35
|
2.07
|
1.84
|
-17.09
|
4.66
|
|||||
|
Adjusted Book Value (₹)
|
29.38
|
27.79
|
26.64
|
25.62
|
3.54
|
23.94
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
-1.33
|
3.63
|
0.49
|
-9.57
|
0.00
|
4.66
|
|||||
|
Free Cash Flow per Share (₹)
|
-2.83
|
1.80
|
-2.00
|
-11.25
|
-5.41
|
-0.46
|
Profitability Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
7.33
|
5.42
|
4.77
|
6.67
|
-40.47
|
4.56
|
|||||
|
ROE (%)
|
5.47
|
4.15
|
3.61
|
5.52
|
-148.03
|
4.77
|
|||||
|
ROA (%)
|
3.88
|
2.76
|
2.51
|
2.29
|
-24.27
|
1.42
|
|||||
|
EBIT Margin (%)
|
9.29
|
6.44
|
3.51
|
3.85
|
4.10
|
4.14
|
|||||
|
Net Margin (%)
|
8.86
|
6.65
|
5.99
|
5.04
|
-52.62
|
2.87
|
|||||
|
Cash Profit Margin (%)
|
15.64
|
14.38
|
13.85
|
13.27
|
-46.86
|
12.23
|
Growth Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
3.39
|
9.66
|
7.47
|
10.73
|
-4.33
|
-4.50
|
|||||
|
EBIT Growth (%)
|
49.07
|
101.46
|
-2.03
|
3.93
|
-5.28
|
-27.21
|
|||||
|
Net Profit Growth (%)
|
38.61
|
19.67
|
27.35
|
110.58
|
-1,856.14
|
135.50
|
|||||
|
EPS Growth (%)
|
38.61
|
19.68
|
27.34
|
103.64
|
-1,856.11
|
136.58
|
|||||
|
Book Value Growth (%)
|
5.70
|
4.34
|
3.98
|
2,002.64
|
-85.21
|
-2.75
|
Valuation Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
0.99
|
0.25
|
1.18
|
0.40
|
5.28
|
4.10
|
|||||
|
Close Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.08
|
0.12
|
0.12
|
0.02
|
10.15
|
1.20
|
|||||
|
Short term debt to equity ratio
|
0.06
|
--
|
--
|
--
|
4.38
|
0.42
|
|||||
|
Current Ratio
|
3.84
|
2.64
|
3.11
|
3.38
|
0.73
|
1.33
|
|||||
|
Quick Ratio
|
1.98
|
1.46
|
1.65
|
1.75
|
0.32
|
0.52
|
|||||
|
Interest Coverage
|
11.64
|
11.77
|
6.43
|
3.88
|
-8.27
|
1.00
|
Operating Efficiency Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
46.76
|
44.53
|
53.20
|
53.28
|
37.10
|
24.44
|
|||||
|
Asset Turnover
|
0.42
|
0.40
|
0.40
|
0.43
|
0.44
|
0.47
|
|||||
|
Receivable days
|
163.95
|
169.80
|
187.55
|
158.38
|
114.34
|
87.86
|
|||||
|
Inventory Days
|
262.96
|
274.03
|
278.04
|
268.55
|
275.80
|
239.08
|
|||||
|
Payable days
|
179.42
|
286.30
|
301.74
|
330.13
|
398.30
|
347.14
|
|||||
|
Cash Conversion Cycle
|
247.48
|
157.53
|
163.86
|
96.80
|
-8.16
|
-20.20
|